HEALTHSCMP WORLD
‘Systemic leap’: China’s drug innovation push yields bumper crop
China's pharmaceutical innovation has seen significant growth, with over 80% of drug approvals in the first half of the year being domestically produced. A total of 38 innovative drugs were approved, 31 of which were home-grown, according to a government official.
Mentioned
Related Signal
Adjacent reporting
- ‘Systemic leap’: China’s drug innovation push yields bumper crop
- China’s drug regulator clears wave of home-grown innovative medicines amid biotech boom
- China’s drug regulator clears wave of home-grown innovative medicines amid biotech boom
- Mainland China funds increase stakes in Hong Kong biotech amid surge of licensing deals
- China’s drug industry pivots to AI-powered candidates to drive next wave of deals
- Mainland China funds increase stakes in Hong Kong biotech amid surge of licensing deals